Pfizer Inc. | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
22,072
9,168
6,986
7,246
21,355
11,188
Depreciation, Depletion & Amortization
6,410
5,537
5,157
5,757
6,269
6,384
Other Funds
109
72
109
196
233
1,387
Funds from Operations
21,157
15,511
13,942
15,816
15,172
16,754
Changes in Working Capital
3,392
1,423
741
85
1,296
927
Net Operating Cash Flow
17,765
16,883
14,689
15,901
16,468
15,827
Capital Expenditures
1,465
1,583
1,496
1,999
2,217
Purchase/Sale of Investments
9,376
4,223
14,638
12,504
2,174
Net Investing Cash Flow
10,625
5,654
2,980
7,811
4,741
Cash Dividends Paid - Total
6,580
6,609
6,940
7,317
7,659
Issuance/Reduction of Debt, Net
6,036
549
1,319
2,573
1,005
Net Financing Cash Flow
14,975
9,986
10,409
8,921
13,035
Net Change in Cash
7,898
1,160
298
1,046
1,253
Free Cash Flow
16,559
15,684
13,292
14,078
14,512
Deferred Taxes & Investment Tax Credit
1,703
317
20
700
2,410
2,205
Net Assets from Acquisitions
15
195
16,466
18,368
1,000
Other Sources
231
347
344
52
650
Change in Capital Stock
14,540
3,998
4,897
3,981
4,138
Exchange Rate Effect
63
83
1,000
215
53
Miscellaneous Funds
-
-
2
-
2
Extraordinaries
-
51
6
-
-
-
About Pfizer
View Profile
